These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32662821)

  • 1. Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis.
    Kaaij MH; van Tok MN; Blijdorp IC; Ambarus CA; Stock M; Pots D; Knaup VL; Armaka M; Christodoulou-Vafeiadou E; van Melsen TK; Masdar H; Eskes HJPP; Yeremenko NG; Kollias G; Schett G; Tas SW; van Duivenvoorde LM; Baeten DLP
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32662821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis.
    Christodoulou-Vafeiadou E; Geka C; Ntari L; Kranidioti K; Argyropoulou E; Meier F; Armaka M; Mourouzis I; Pantos C; Rouchota M; Loudos G; Denis MC; Karagianni N; Kollias G
    Arthritis Res Ther; 2020 Oct; 22(1):232. PubMed ID: 33023659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.
    Lories RJ; Derese I; de Bari C; Luyten FP
    Arthritis Rheum; 2007 Feb; 56(2):489-97. PubMed ID: 17265484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis.
    Hammoura I; Fiechter RH; Bryant SH; Westmoreland S; Kingsbury G; Waegell W; Tas SW; Baeten DL; van de Sande MGH; van Tok MN; van Duivenvoorde LM
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Transmembrane TNF Drives Development of Ectopic Lymphoid Structures in the Bone Marrow and B Cell Lineage Alterations in Experimental Spondyloarthritis.
    Kaaij MH; Rip J; Jeucken KCM; Kan YY; van Rooijen CCN; Saris J; Pots D; Frey S; Grootjans J; Schett G; van Duivenvoorde LM; Nolte MA; Hendriks RW; Corneth OBJ; van Hamburg JP; Baeten DLP; Tas SW
    J Immunol; 2021 Nov; 207(9):2337-2346. PubMed ID: 34561228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral joint inflammation in early onset spondyloarthritis is not specifically related to enthesitis.
    Paramarta JE; van der Leij C; Gofita I; Yeremenko N; van de Sande MG; de Hair MJ; Tak PP; Maas M; Baeten D
    Ann Rheum Dis; 2014 Apr; 73(4):735-40. PubMed ID: 23619158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.
    Melis L; Van Praet L; Pircher H; Venken K; Elewaut D
    Ann Rheum Dis; 2014 Jun; 73(6):1223-31. PubMed ID: 23740233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis Model.
    Kaaij MH; van Hamburg JP; van Rooijen CCN; Grüneboom A; Kan YY; Pots D; Schett G; van Ruijven LJ; van Duivenvoorde LM; Huitema LFA; Baeten DLP; Tas SW
    Arthritis Rheumatol; 2023 Jul; 75(7):1152-1165. PubMed ID: 36657110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.
    Jacques P; Lambrecht S; Verheugen E; Pauwels E; Kollias G; Armaka M; Verhoye M; Van der Linden A; Achten R; Lories RJ; Elewaut D
    Ann Rheum Dis; 2014 Feb; 73(2):437-45. PubMed ID: 23921997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis.
    Yeremenko N; Noordenbos T; Cantaert T; van Tok M; van de Sande M; Cañete JD; Tak PP; Baeten D
    Arthritis Rheum; 2013 Jan; 65(1):174-85. PubMed ID: 22972410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
    Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?
    Berthelot JM; Le Goff B; Maugars Y
    Arthritis Res Ther; 2019 Nov; 21(1):239. PubMed ID: 31722720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.
    Min HK; Kim JK; Lee SY; Kim EK; Lee SH; Lee J; Kwok SK; Cho ML; Park SH
    J Transl Med; 2016 Jun; 14(1):190. PubMed ID: 27350608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis.
    Venken K; Jarlborg M; Decruy T; Mortier C; Vlieghe C; Gilis E; De Craemer AS; Coudenys J; Cambré I; Fleury D; Klimowicz A; Van den Bosch F; Hoorens A; Lobaton T; de Roock S; Sparwasser T; Nabozny G; Jacques P; Elewaut D
    Ann Rheum Dis; 2023 Aug; 82(8):1076-1090. PubMed ID: 37197892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis.
    van Tok MN; van Duivenvoorde LM; Kramer I; Ingold P; Pfister S; Roth L; Blijdorp IC; van de Sande MGH; Taurog JD; Kolbinger F; Baeten DL
    Arthritis Rheumatol; 2019 Apr; 71(4):612-625. PubMed ID: 30390386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation
    Chen S; van Tok MN; Knaup VL; Kraal L; Pots D; Bartels L; Gravallese EM; Taurog JD; van de Sande M; van Duivenvoorde LM; Baeten DL
    Front Immunol; 2019; 10():2344. PubMed ID: 32194539
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
    Santinon F; Batignes M; Mebrek ML; Biton J; Clavel G; Hervé R; Lemeiter D; Breckler M; Busato F; Tost J; Ziol M; Boissier MC; Decker P; Semerano L; Bessis N
    Arthritis Rheumatol; 2020 Apr; 72(4):576-587. PubMed ID: 31609517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
    Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
    Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints.
    Poggenborg RP; Pedersen SJ; Eshed I; Sørensen IJ; Møller JM; Madsen OR; Thomsen HS; Østergaard M
    Rheumatology (Oxford); 2015 Jun; 54(6):1039-49. PubMed ID: 25431482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.